Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioSenic SA Interim / Quarterly Report 2019

Nov 25, 2019

3920_rns_2019-11-25_ff7fbf21-91ab-4aa4-88d1-4bd35d0633c3.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

ASSETS
(in thousands of euros)
30-09-19 31-12-18
Non-current assets 3.020 3.015
Formation expenses 1.287 1.202
Intangible assets 75 171
Property plant and equipment 243 113
Financial fixed assets 1.414 1.528
Current assets 16.834 16.945
Amounts receivable for more than one year 3.856 3.856
Trade and other receivables 3.228 5.236
Investments 1.449 3.449
Cash and cash equivalents 8.202 4.337
Deferred charges and accrued income 99 68

TOTAL ASSETS 19.854 19.960

30-09-19 31-12-18
5.215 7.809
15.807 12.532
3.903 6.022
(14.495) (10.744)
8.059 4.240
6.580 7.910
1.684 1.643
3.098 3.507
427 753
1.125 1.730
245 278
14.638 12.151
(in thousands of euros) For the 9 or 12-months period ended
30-09-19 31-12-18
Operating income 1.681 15.069
Turnover 0 1.000
Own construction capitalised 0 10.112
Other operating income 1.681 3.957
Operating charges (12.100) (29.143)
Services and other goods (7.516) (11.312)
Remuneration, social security, pensions (2.581) (3.889)
Depreciation and amounts written off fixed assets (794) (12.944)
Other operating charge (1.209) (999)
Operating profit/(loss) (10.419) (14.074)
Financial income 2 4
Financial expenses (94) (103)
Result Profit/(loss) before taxes (10.511) (14.173)
Income taxes 0 (100)
TOTAL COMPREHENSIVE INCOME OF THE PERIOD (10.511) (14.273)